Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

­­A Radiation Oncology Departmental Policy for the 2019 Novel Coronavirus (COVID-19) Pandemic

Version 1 : Received: 21 March 2020 / Approved: 23 March 2020 / Online: 23 March 2020 (09:55:24 CET)

How to cite: Rao, Y.J.; Provenzano, D.; Gay, H.A.; Read, P.W.; Ojong, M.; Goyal, S. ­­A Radiation Oncology Departmental Policy for the 2019 Novel Coronavirus (COVID-19) Pandemic. Preprints 2020, 2020030350. https://doi.org/10.20944/preprints202003.0350.v1 Rao, Y.J.; Provenzano, D.; Gay, H.A.; Read, P.W.; Ojong, M.; Goyal, S. ­­A Radiation Oncology Departmental Policy for the 2019 Novel Coronavirus (COVID-19) Pandemic. Preprints 2020, 2020030350. https://doi.org/10.20944/preprints202003.0350.v1

Abstract

The COVID-19 pandemic is placing unprecedented stress on healthcare systems around the world. Although Radiation Oncology Departments are not at the frontline of fighting this infectious disease, it is important to implement COVID-19 policies to reduce risk of staff and patient exposure, and to limit the risk of department shutdown or downtime. This brief report describes the policy implemented at George Washington University Radiation Oncology to manage the risks of COVID-19. This includes a General Statement related to the priorities of the Radiation Oncology department, a screening procedure for new and follow-up patients, management policies for critical and non-critical patients with COVID-19 or under quarantine, a policy for the management of patients currently under treatment who are diagnosed or placed in quarantine, a clinical escalation action plan, guidelines for staff meetings and travel, and procedure management. This policy was implemented at George Washington University Radiation Oncology after the first case of COVID-19 was reported in Washington DC on March 7, 2020.

Keywords

COVID-19; SARS-CoV-2; coronavirus; novel coronavirus; department policy; radiation oncology

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.